<DOC>
	<DOCNO>NCT01305083</DOCNO>
	<brief_summary>This randomize , double blind , placebo control , multicentric , clinical study ass efficacy safety Udenafil ( 100 mg ) tablets patient suffer erectile dysfunction ( ED ) .</brief_summary>
	<brief_title>Efficacy Safety Study Udenafil Tablets Erectile Dysfunction .</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Udenafil</mesh_term>
	<criteria>Male patient 18 60 year age . Patients stable , monogamous sexual relationship female partner least 6 month willing maintain relationship duration study . Patients establish diagnosis erectile dysfunction ( ED ) organic , psychogenic mixed etiology least 6 month duration . Patient willing attempt least one sexual intercourse week entire treatment . Patients total erectile failure sexual disorder hypoactive sexual desire . Patients previously fail respond PDE5 inhibitor like Sildenafil , Vardenafil Tadalafil . Patients use erectile dysfunction therapy within 14 day ( 2 week ) prior enter study ( i.e . visit 1 ) . Patients hypogonadism anatomical deformity penis severe penile fibrosis Peyronie 's disease penile trauma . Patients history major psychiatric disorder . Patients history significant pathological cardiovascular condition : congestive heart failure , lifethreatening arrhythmia ischemic heart disease within past 6 month . Patients history central nervous system disorder stroke , transient ischemic attack spinal cord injury radical prostatectomy radical pelvic surgery . Patients hypotension ( &lt; 90/50 ) uncontrolled hypertension ( &gt; 170/100 ) , uncontrolled diabetes , hepatic impairment ( SGOT SGPT level &gt; 3 x Upper Normal Limit ) , renal impairment ( serum creatinine &gt; 2.5mg/dl ) , hematological disorder bleed disorder . Patients history retinitis pigmentosa , proliferative diabetic retinopathy nonarteritic anterior ischemic optic neuropathy ( NAION ) . Patients history sickle cell disease , multiple myeloma , leukemia disorder may cause priapism . Patients concomitant treatment nitrates/nitrites ( NO ) donor , CYP3A4 inhibitor , CYP3A4 inducer , anticoagulant , androgen , antiandrogens trazodone . Patients know hypersensitivity PDE 5 inhibitor like Sildenafil , Vardenafil Tadalafil . Patient known diagnosis AIDS positive HIV result study screen visit . Patients serious concurrent illness malignancy . Patients continue history alcohol / drug abuse . Participation another clinical trial past 30days .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>